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Abstract
Introduction: The birth of most mammals features a dramatic increase in
oxygen while placenta-derived hormones such as b-estradiol and progesterone
plummet. In experimental newborn animals, transiently elevated oxygen con-
centrations cause death of neurons, astrocytes, and oligodendrocyte precursors.
High oxygen has been associated with cerebral palsy in human preterm infants
while progesterone is being used to prevent preterm delivery and investigated
as a neuroprotective agent. Methods: In this study, we investigated the effects
of hyperoxia (80% O2 for 24, 48, and 72 h) on cultured C8-D1A astrocytes in
the presence or absence of progesterone at concentrations ranging from 109 to
105 mol/L. Results: Hyperoxia measured by methytetrazolium assay (MTT)
reduced cell viability, increased release of lactate dehydrogenase (LDH), reduced
carboxyfluorescein diacetate succinimidyl ester (CFSE)-assessed cell prolifera-
tion, and downregulated Cylin D2 expression. Progesterone did not affect any
of these hyperoxia-mediated indicators of cell death or malfunctioning. Real-
time PCR analysis showed that hyperoxia caused downregulation of the proges-
terone receptors PR-AB und PR-B. Conclusions: Our experiments showed that
there was no protective effect of progesterone on hyperoxia-inducted cell
damage on mouse C8-D1A astrocytes. Down regulation of the progesterone
receptors might be linked to the lack of protective effects.
Introduction
Neurodevelopmental impairment is the major long-term
morbidity of preterm infants, with the risk for special
educational needs rising strongly with decreasing gesta-
tional age (MacKay et al. 2010). For a long time, much of
this problem had been attributed to intraventricular hem-
orrhage and cystic periventricular leukomalacia. However,
of preterm infants below 1000 g birth weight but a nor-
mal head ultrasound, nearly 30% have been found to
display cerebral palsy or low mental skills (Laptook et al.
2005). Thus, physiological changes resulting from leaving
the intrauterine environment that strike a preterm infant
prematurely are being investigated as noxious stimuli for
the developing brain.
The placenta supplies the fetus with high amounts of
17b-estradiol and progesterone that increase during the
course of the gestation. After delivery of a premature
infant, this placental supply is disrupted, resulting in a
rapid decrease in both 17b-estradiol and progesterone.
Replacement of these placental hormones aiming at
intrauterine conditions has been hypothesized to be bene-
ficial. Supplementation of 17b-estradiol and progesterone
has been suggested to help improve neurocognitive out-
come in preterm infants who are prematurely deprived of
maternal estrogen. In extremely low birth weight infants
who had been randomized to receive or not to receive
postnatal replacement of 17b-estradiol and progesterone,
neurodevelopmental follow-up at 5 years corrected age
suggested a significant time–response relationship between
hormone replacement and cerebral palsy, with every day
of treatment significantly reducing the risk for cerebral
palsy (Trotter et al. 2012).
The birth of mammals is associated with a rapid increase
in oxygen availability, featuring a sustained 3–4 fold rise of
oxygen tension within a few minutes. For the preterm
infant, this normoxia is already a hyperoxic environment
as the fetus is only exposed to a comparatively low oxygen
concentration. The developing brain of the preterm infant
is therefore exposed to increased oxygen levels weeks or
months before the postnatal oxygen surge would be antici-
pated. We have repeatedly shown in both cultured cells
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and newborn rodents that an oxygen increase in similar
magnitude causes cell damage to the immature rat brain,
killing neurons, astrocytes, and oligodendrocyte precursors
(Felderhoff-Mueser et al. 2004; Gerstner et al. 2006; Hupp-
mann et al. 2008; Schmitz et al. 2011; Yousuf et al. 2013).
17b-estradiol ameliorates this oxygen toxicity in the infant
rat brain. This protective effect is reversed by the estradiol
antagonist tamoxifen and cannot be reproduced by 17a-
estradiol (Asimiadou et al. 2005). 17b-estradiol produces
significant dose-dependent protection against oxygen-
induced apoptotic cell death of primary oligodendrocytes
and attenuates loss of myelin basic protein observed with
high oxygen (Gerstner et al. 2007). Protective effects of
17b-estradiol for the neonatal brain have been also been
observed after other insults, such as hypoxia–ischemia
(Nunez et al. 2007). In contrast, the effects of progesterone
are less well characterized. Progesterone has been reported
to be neuroprotective after focal or global hypoxia/is-
chemia (Jiang et al. 1996; Gonzalez-Vidal et al. 1998;
Gibson and Murphy 2004; Ishrat et al. 2009), experimental
trauma (Thomas et al. 1999), poisoning (Ishihara et al.
2012), and infections (Yousuf et al. 2013). Progesterone,
however, has also been reported to block estrogen-
mediated protection (Carroll et al. 2008), possibly via
downregulating estrogen receptors (Jayaraman and Pike
2009). Thus, it is important to dissect the action of proges-
terone on individual cell lineages.
In the set of experiments reported here, we first investi-
gated the effect of transient hyperoxia on cultured murine
C8-D1A astrocytes, hypothesizing that increased oxygen is
apt to cause apoptosis and impede proliferation. We then
asked if hyperoxia-mediated cell damaged could be res-
cued or ameliorated by progesterone.
Materials and Methods
Cell culture and treatment
The C8-D1A astrocyte cell line (astrocytic type I clone,
GFAP positive) was cloned from mouse cerebellum and
purchased from American Type Culture Collection
(ATCC CRL-2541, LGC Standards, Wesel, Germany)
(Alliot and Pessac 1984). Cells were cultured in
Dulbecco’s modified Eagle medium (DMEM; Biochrom,
Berlin, Germany) containing glucose, 10% heat-inacti-
vated calf serum (FCS; Biochrom) and 2% L-glutamine
(Biochrom). To exclude interference of any steroid hor-
mones possibly present in FCS, FCS was charcoal filtered
prior to use (Activated charcoal C 9157, dextran D 1390;
Sigma-Aldrich, St. Louis, MO) (Eckert and Katzenellenbo-
gen 1982). Phenol red-free medium (RPMI; Biochrom)
was used in all experiment in hyperoxia as well as in
experiment with progesterone.
Cells were maintained as monolayers at 37°C, 5% CO2/
15% N2/21% O2 (normoxia) or 5% CO2/15% N2/80% O2
(hyperoxia) with medium replacement every 2–3 days.
Water-soluble progesterone (P 7556; Sigma-Aldrich)
was dissolved as a stock solution of 1 mmol/L in distilled
aqua and diluted to concentrations of 105 mol/L,
107 mol/L, and 109 mol/L in culture medium before
use. RU486 (Sigma-Aldrich) was prepared in dimethylsul-
foxide (DMSO, Sigma Aldrich) as a stock solution of
10 mmol/L, which was diluted to the working concentra-
tion of 10 lmol/L with culture medium prior to use.
Experiment set-up
Astrocytes were seeded into 96-wells microtiter plates
(30,000/well in 100 lL medium) and incubated for 24 h
in normoxia. Progesterone or RU486 was added in the
mentioned concentrations. The plates were incubated for
further 24–72 h. To measure lactate dehydrogenase
(LDH) release, 50 lL of the cell culture supernatant was
collected from each well and transferred to a fresh plate.
The remaining 50 lL of each well were used for colori-
metric viability assays.
Analysis of cell viability
Colorimetric viability assay
After exposure of astrocytes in 96-well plates to hyperoxia
or normoxia, measurements of reduction in 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
(MTT; Sigma-Aldrich) were performed to estimate cell
viability. MTT is reduced by active mitochondria in vital
cells and consequently, the amount of formazan is pro-
portional to the number of living cells. MTT was pre-
pared as a 5 mg/mL stock solution in phosphate-buffered
saline (PBS; Biochrom). A quantity of 50 lL of each well
was collected and transferred to a corresponding microti-
ter plate for LDH release assay.
A quantity of 5 lL of MTT was added to each well
(final concentration 0.5 mg/mL) for 3 h. The reaction
was stopped by 50 lL 10% Sodium Dodecyl Sulfate (SDS;
Sigma-Aldrich). Absorbance was measured after incuba-
tion in a microplate reader (Bio-Rad, Munich, Germany)
at 570 nm, with a reference wavelength of 630 nm.
Analysis of cell death
Lactate dehydrogenase (LDH) release
The lactate dehydrogenase release was measured using
cytotoxicity detection kit (Roche Diagnostics, Mannheim,
Germany). The test is based on the measurement of LDH
activity released from damaged cells. Triton-X 100 served
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as positive control. LDH release was calculated as percent
of total release with Triton-X 100. Absorbance was
detected in a microplate reader (Bio-Rad) at 490 nm and
a reference wavelength 600 nm.
Cell death detection ELISAplus
To verify the results of the LDH release assay and to dif-
ferentiate necrosis and apoptosis, we performed the sand-
wich-enzyme-immunoassay ELISA for cell death
detection. Apoptosis was detected in the cell lysate, necro-
sis in the supernatant of the cell culture medium of each
well. The test uses mouse monoclonal antibodies directed
against DNA and histones (Anti-histone-biotin and Anti-
DNA-POD – peroxidase-conjugated monoclonal antibody
from mouse), which allow the specific determination of
mono- and oligonucleosomes in the cytoplasmatic frac-
tion of cell lysates. Mono- and oligonucleosomes are
released into the cytoplasm of cells that die from apopto-
sis, whereas necrotic cells do not show nucleosomal frag-
mentation (Salgame et al. 1997; Heinrich et al. 2009).
The antibodies bind to the components building an
immunocomplex binding to the streptavidin-coated plate.
ELISA assay was performed as described in the guidelines
(Roche, Cell Death Detection ELISAplus Manual). Absor-
bance was measured with a microplate reader at 405 nm
and 490 nm.
Analysis of cell proliferation
Flow cytometry
For analysis of cell proliferation, C8-D1A astrocytes were
labeled with carboxyfluorescein diacetate succinimidyl
ester (CFSE; Molecular Probes, Eugene, Oregon), which is
passed down to daughter cells during cell division. CFSE
diffuses into astrocytes where acetate groups are split by
intracellular esterases. The result is the fluorescent car-
boxyfluorescein succinimidyl ester which loses intensity of
fluorescence with increasing cell proliferation (Lyons and
Parish 1994). To identify maximum fluorescence of non-
proliferated cells, fresh astrocytes were labeled with CFSE
as described prior to measurement.
A 5 mmol/L stock solution of CFSE, diluted in DMSO
(Sigma Aldrich) was prepared. Prior to use, the working
concentration of 5 lmol/L was diluted in PBS. Confluent
astrocytes were harvested, centrifuged (5 min, 1000 rpm),
and resuspended in 5 mL of prewarmed (37°C) CFSE
solution with a concentration of 106 cells/mL. Cells were
incubated for 15 min at 37°C, loading solution was
replaced with medium and 200,000 astrocytes were seeded
in each well of a 6-well plate for further investigation.
After exposure to 21% O2 or 80% O2 (24–48 h), cells
were mechanically removed from the microtiter plate,
centrifuged, resuspended in 1 mL PBS, and transferred to
a BD Falcon 5 mL round-bottom tube. We performed
flow cytometry with 10,000 cells per measurement using
FACS Canto II flow cytometer (Becton Dickinson
Biosciences, San Jose, CA).
RT-PCR
Astrocytes were cultured in RPMI medium with 10%
charcoal-filtered FCS and 2% L-Glutamin until cells were
confluent. Cellular RNA was isolated using InviTrap Spin
Universal MiniKit (Stratec molecular, Berlin, Germany)
and DNA was removed with DNAse I (Roche). Using the
One-Step RT-PCR Kit (Qiagen), the resulting cDNA
(1 lL) was amplified with polymerase chain reaction
(PCR) using the oligonucleotide primers for progesterone
receptor PR-AB and PR-B (TIB MOLBIOL, Berlin,
Germany) shown in Table 1 (PR-AB# and PR-B#).
PCR-mediated cDNA amplification was done in 40 cycles
(each 60 sec) comprising 94°C for denaturing, 60°C for
annealing, and elongation at 72°C. Amplified cDNA was
applied to agarose gel electrophoresis (1% (w/v) agarose
gel containing 0.00003% (v/v) ethidium bromide (Roth,
Karlsruhe, Germany), which was also used for fluores-
cence measuring and qualitative analysis. PCR products
were visualized and photographed using the UV recorder
UV solo and Video Copy Processor.
Quantitative real-time PCR
For quantitative measurement of progesterone receptors,
astrocytes were cultivated in 6-well plates and exposed to
either 21% or 80% O2 for 24 h. Total astrocytic RNA
was extracted from snap-frozen probes using phenol–
chloroform extraction. To reduce contamination with
DNA, probes were DNAse I treated (Roche). Transcrip-
tion of mRNA into cDNA took place for 1 h at 42°C in
the presence of 1 lL M-MLV reverse transcriptase
(200 U/lL) and 0.5 lL RNAsin (40 U/lL) (Promega,
Madison, WI).
Real-time PCR was carried out using KAPATM PROBE
FAST Universal qPCR Mastermix (Kapa Biosystems,
Woburn, MA). Samples were labeled with 6-carboxy-
fluoresceine (FAM) at 500 end and the quencher 6-car-
boxy-tetramethylrhodamine (TAMRA) at 30 end. Probes
were investigated as triplicates in a 96-well plate. The
following cycles were performed: 3 min at 95°C for
denaturation and activation of polymerases, 45 cycles a
15 sec at 95°C for cyclic denaturation, and 45 cycles a
1 min at 65°C for hybridization and extension of
oligonucleotides. The quantification of mRNA-expression
of PR-AB, PR-B, Cycline D2, and the housekeeping gene
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hypoxanthine-guanine phosphoribosyltransferase (HPRT)
was carried out using standard 2DDCT method (Livak
and Schmittgen 2001). Internal control was carried out by
b-actin control-PCR. The primers are listed in Table 1
and were obtained from BioTez (Berlin, Germany).
Statistical analysis
Data were analyzed in GraphPad Prism 6.05 (GraphPad
Software, San Diego, CA, RRID:SCR_002798). The dia-
grams shown are the summaries of all essays. Experiments
were repeated as indicated. Values are presented as mean
and standard error of the mean (SEM). We performed
Student’s t-test or one-way ANOVA test with Bonferroni
post hoc test to compare significant differences between
groups. P < 0.05 was considered statistically significant.
Results
Effects of hyperoxia on C8-D1A astrocytes
C8-D1A astrocytes lose viability after exposure to
hyperoxia (80% O2)
Measurements of methyltetrazolium absorption revealed a
significant loss of viability after exposure to hyperoxia for
24 h compared to controls (60.3  4.1%; P < 0.001).
The decline of vital astrocytes showed a time-dependent
progression. Incubation for 48 and 72 h in hyperoxia
reduced cell viability further (50.3  5.8%; 46.5  3.7%;
P < 0.001) (Fig. 1A). Cell death, measured by LDH
release, increased significantly after 24, 48, and 72 h of
exposure compared to control cells (17.4  0.8%;
P < 0.05; 27.7  1.6%, and 73.8  4.0%; P < 0.0001)
(Fig. 1B).
Table 1. Primer.




Forward CAg Tgg Tgg ATT TCA TCC ATg NM_008829.2*
Reverse CTT CCA gAG ggT Agg Tg
PR-B#
Forward ggA ggC AgA AAT TCC AgA CC NM_008829.2*
Reverse gAC AAC AAC CCT TTg gTA gC
PR-AB$
Forward TCC gCT TCT AAA gAg CAA ACCT NM_008829.2*
Reverse Agg AgC AgA AAA CCg TgA ATCT
Probe FAM TgT CAC TCT ggT CCC
AAA TAMRA
PR-B$
Forward CTC ATA ggg AAg gAg gCA gAAA NM_008829.2*
Reverse ggA ggg AgT CAA CAA CgA gTC TAA
Probe FAM AgC AgA CTC TTA gAC AgT
gT TAMRA
Cyclin D2
Forward CgT ACA TgC gCA ggA TggT NM_009829.3
Reverse AAT TCA Tgg CCA gAg gAA AgAC
Probe FAM Tgg ATg CTA gAg gTC TgT gA
TAMRA
mHPRT
Forward ATC ATT ATg CCg Agg ATT Tgg AA NM_013556.2
Reverse TTg AgC ACA CAg Agg gCCA
Probe FAM-Tgg ACA ggA CTg AAA gAC
TTg
CTC gAg ATg TAMRA
b-Actin
Forward CCC TAA ggC CAA CCg TgA
AAA AgA Tg
NM_007393.3
Reverse gAA CCg CTC gTT gCC AAT
AgT GA Tg
*In order to elucidate which progesterone isoforms is predominantly
expressed in the C8-1DA astrocyte cell lines, we amplified two iso-
forms of the PR-AB and PR-B.
#Oligonucleotide sequence used for RT-PCR in normoxia (Fig. 3A).
$Oligonucleotide sequence used for quantitative RT-PCR in hyperoxia
(Fig. 3B).
Figure 1. (A) Colorimetric viability assay (metabolism of MTT) after
24, 48 and 72 h in hyperoxia. C8-D1A astrocytes showed a time-
dependent significant loss of cell viability compared to control cells in
normoxia. (data are means  SEM; n = 5; one-way ANOVA with
Bonferroni post hoc test; ***P < 0.001). (B) Cytotoxicity detection
test (LDH release) after 24, 48 and 72 h in hyperoxia. Astrocytes
showed a time-dependent significant increase in LDH release. (data
are means  SEM; n = 5; one-way ANOVA test with Bonferroni post
hoc test; *P < 0.05, ****P < 0.0001).
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Hyperoxia induces apoptosis in C8-D1A astrocytes
Cell Death detection ELISAplus was used to investigate cell
death in C8-D1A astrocytes in hyperoxia. Cell Death
Detection ELISA revealed a significant rise of released
mono- and oligonucleosomes in the cytoplasm of hyper-
oxia-treated cells compared to cells in normoxia (1.16 vs.
0.94; P < 0.05) (Fig. 2A).
Hyperoxia causes inhibition of cell proliferation in
C8-D1A astrocytes
Flow cytometry was used to determine changes in prolif-
eration. In comparison to cells incubated in normoxia,
astrocytes exposed to hyperoxia showed a significant
reduction in cell division after 24 h. C8-D1A astrocytes
cultured in normoxia showed a proliferation rate of
38  3.2%, whereas hyperoxia-exposed cells presented a
reduced cell division of 18.4  1.4% (P < 0.0001)
(Fig. 2B). After 48 h, the evaluation of proliferation by
flow cytometry revealed a cell division rate of 73% for
astrocytes incubated in normoxia, whereas exposition to
hyperoxia resulted in a significantly lower proliferation
rate of 27% (not shown).
Hyperoxia suppresses expression of Cyclin D2
To verify the results of flow cytometry, we used real-time
PCR to analyze the expression of the cell cycle regulating
protein, Cyclin D2. After 24 h in hyperoxia, C8-D1A
astrocytes showed a significantly reduced expression of
Cyclin D2 in real-time PCR analysis. After hyperoxia, the
expression of the protein was decreased to 67.8  5.7%
(P < 0.01) (Fig. 2C).
Effects of progesterone in C8-D1A
astrocytes
Receptors PR-AB and PR-B are expressed in
C8-D1A mouse astrocytes
To determine the expression of PR-AB and PR-B in C8-
D1A cells, mRNA of both progesterone receptors were
assessed using RT-PCR. The investigation revealed that
PR-AB (204 bp) and PR-B (196 bp) are both expressed
in cultured cells. (Fig. 3A).
Impact of hyperoxia on expression of
progesterone receptors
Clarifying the question why progesterone could not medi-
ate as a protective agent against hyperoxia-induced cell
damage of astrocytes, we analyzed the quantitative expres-
sion of progesterone receptors by real-time PCR, employ-
ing primers for PR-AB and PR-B receptors (see Table 1).
After 24 h in hyperoxia, the expression of both receptors
was significantly reduced (PR-AB 27.9  5.9%;
P < 0.0001 and PR-B 45.1  9.3%; P < 0.01) in contrast
to cells incubated in normoxia (Fig. 3B).
Figure 2. (A) Cell Death Detection ELISAplus after 24 h in hyperoxia.
C8-D1A-astrocytes presented significant increase in mono- and
oligonucleosomes released into cytoplasm. (data are means  SEM;
n = 3; students t-test, *P < 0.05). (B) Flow cytometry with CFSE-
labeling after 24 h in hyperoxia. Treated astrocytes showed a
significantly reduced proliferation rate in comparison to control cells
in normoxia. (data are mean  SEM; n = 4; students t-test,
****P < 0.0001). (C) Real-time PCR analysis after 24 h in hyperoxia.
Astrocytes significantly reduced the expression of Cyclin D2. (data are
mean  SEM; n = 5; students t-test, **P < 0.01).
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Progesterone does not prevent hyperoxia-induced
cell damage
After 24 h in normoxia, cell viability of C8-D1A astrocytes
was significantly reduced in the presence of progesterone at
concentrations of 105 mol/L, 107 mol/L, and 109 mol/L
(76.1  3.9%; P < 0.01; 67.9  5.5%; P < 0.001;
78  4.6; P < 0.05). Moreover, the exposure of astrocytes
to hyperoxia caused a significant loss of cell viability com-
pared to control cells in normoxia (69.4  2.9%;
P < 0.001), which could not be attenuated by progesterone
in all tested concentrations (74.3  3.0%; P < 0.001;
71.6  2.9%; P < 0.001; 68.1  3.6%; P < 0.001)
(Fig. 4A). The investigated doses of progesterone did not
have an influence on LDH release in normoxia after 24 h
as well as in hyperoxia. Cell death increased after 24 h of
hyperoxia without any protective effect of progesterone
(10.0  0.4% for controls in normoxia vs. 17.8  1.1%
for controls in hyperoxia; P < 0.0001) (Fig. 4B).
Progesterone does not cause inhibition of cell
proliferation in C8-D1A astrocytes
To investigate the influence of progesterone on cell prolif-
eration, flow cytometry was performed after exposure to
different concentrations of progesterone. Hyperoxia for
24 h induced a significant reduction in cell proliferation
compared to normoxia (38.5  3.2% for controls in nor-
moxia vs. 18.1  1.4% for controls in hyperoxia;
P < 0.0001). Progesterone showed no influence weather
in hyperoxia or in normoxia (Fig. 4C).
Progesterone does not induce apoptosis or
necrosis in C8-D1A astrocytes
Cell Death Detection ELISAplus and LDH-assay were used
to detect apoptosis and necrosis in C8-D1A astrocytes.
Figure 5A illustrates that progesterone did not induce
apoptosis in C8-D1A astrocytes during the investigated
times. The enrichment factor determined by ELISA assay
was not increased. Moreover, LDH-assay revealed that
progesterone did not cause elevated release of lactate
dehydrogenases which excludes cell death (Fig. 4B).
Effects of progesterone on cell proliferation of
C8-D1A astrocytes in normoxia
Regarding the results of the colorimetric viability assay in
normoxia, we wanted to define effects of progesterone on
cultured astrocytes. Figure 5B shows that 24 h of incuba-
tion in normoxia did not reveal a modification of the
number of proliferating cells at presence of progesterone.
There was an increase in proliferation after 48 h, but no
effect of progesterone (37.8  3.1% to 72.9  2.0%;
P < 0.0001).
RU486 re-establishes cell viability of
progesterone-treated astrocytes in normoxia
To see whether the progesterone antagonist RU486
re-establishes the cell viability of C8-D1A astrocytes in
normoxia, we treated cells with both progesterone
107 mol/L and 10 lmol/L RU486. After 24 h, astrocytes
showed a significant reduction in cell viability at presence
of progesterone 107 mol/L (65.0  5.7%; P < 0.0001).
RU486 antagonized this effect significantly even though
the original cell amount was not achieved (88.0  5.9%;
P < 0.05). This may be explained by the DMSO effect as
vehicle for RU486. DMSO alone reduced cell viability
(54.4  3.0%; P < 0.0001). The DMSO concentration
was 0.1% in RU486 as well as in DMSO alone, and con-
sequently, the effect of RU486 was reduced based on the
toxicity of DMSO (Fig. 6).
Discussion
In contrast to our initial hypothesis, experiments of this
study showed that treatment with progesterone does not
Figure 3. (A) Real-time PCR analysis of progesterone receptor AB (PR-
AB) and –B (PR-B) in normoxia. Base pair count of PR-AB at 204 bp and
PR-B at 196 bp. Picture shows one of three experiments. (B) Real-time
PCR analysis after 24 h in hyperoxia. PR-AB and PR-B are significantly
decreased after exposure. White column shows full expression of
receptors in normoxia. (data are means  SEM; n = 4; one-way ANOVA
test with Bonferroni post hoc test (**P < 0.01, ****P < 0.0001).
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have a protective effect on hyperoxia-induced cell damage
of mouse C8-D1A astrocytes. The rapid downregulation
of progesterone receptors in high oxygen levels (80% O2)
could be the key answer for this missing protection.
In our study, we described a reduced cell proliferation
rate of 18  1.4% due to hyperoxia. Primary astrocytes
showed an inhibition of cell proliferation after 48 h expo-
sure to 80% O2 measured by a significant reduction of
Ki67-labeled cells (Schmitz et al. 2011).
Moreover, progesterone showed inhibiting impacts
(MTT metabolism) on cultured astrocytes in normoxia.
Inhibiting effects of progesterone have been described in
other experimental settings as well. In the SK-N-AS
human neuroblastoma cell line, doses of 1 lmol/L to
80 lmol/L reduced significantly the reduction of cell via-
bility in MTT-metabolism. This effect was not blocked by
RU486. Moreover, concentrations of 50 and 100 mg/kg
progesterone inhibited the growth of neuroblastoma in
nude mice in terms of depressing cell proliferation and
Figure 5. (A) Cell Death Detection ELISAplus after 24 and 48 h in
normoxia treated with progesterone in concentrations of 105 mol/L,
107 mol/L, and 109 mol/L. C8-D1A astrocytes are not affected by
apoptosis at presence of progesterone. (data are means  SEM;
n = 3; one-way ANOVA test and Bonferroni post hoc test) (B) Flow
cytometric measurements after CFSE-labeling after 24 and 48 h in
normoxia. There is no impact of progesterone on cell proliferation
within 24 h. After 48 h incubation, all cells proliferated significantly.
(data are means  SEM; n = 3; one-way ANOVA test and Bonferroni
post hoc test, ****P < 0.0001).
Figure 4. (A) Colorimetric viability assay after 24 h in hyperoxia
treated with progesterone in concentrations of 105 mol/L, 107 mol/L
and 109 mol/L. Cell viability of C8-D1A astrocytes decreased
significantly at presence of progesterone in normoxia and hyperoxia.
Exposure to hyperoxia induced a significant reduction in cell viability
exposed to untreated controls in normoxia. Progesterone at the
concentrations indicated did not attenuate the hyperoxia-induced
reduction in cell viability. (data are means  SEM; n = 4; one-way
ANOVA test and Bonferroni post hoc test, **P < 0.01,
****P < 0.0001). (B) Cytotoxicity detection test after 24 h in
hyperoxia treated with different progesterone concentrations.
Astrocytes showed significant increase in LDH release in hyperoxia.
Progesterone could not decrease hyperoxia-induced cell death. In
normoxia, progesterone did not induce LDH release. (data are
means  SEM; n = 3; one-way ANOVA test with Bonferroni post
hoc test, ****P < 0.001). (C) Flowcytometry with CFSE-labeling
after 24 h in hyperoxia treated with different progesterone
concentrations. At presence of progesterone, the proliferation rate
did not change in comparison to the corresponding cells in
normoxia and hyperoxia. Proliferation rate dropped under hyperoxia.
(data are means  SEM; n = 4; one-way ANOVA and Bonferroni
post hoc test, ****P < 0.0001).
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inducing apoptosis (Atif et al. 2011). Exogenous adminis-
tration of progesterone and its metabolite allopreg-
nanolone may worsen hypoxic-ischemic brain injury in
immature rats. Reduced hemispheric volume and
increased neuropathologic injury occurred in a dose- and
age-dependent fashion. This effect was especially devel-
oped in the first week of life, but emerged equally in all
brain regions studied (cortex, thalamus, striatum and tha-
lamus; Tsuji et al. 2012). Negative effects of progesterone
were also seen in experimental models of stroke with
ovariectomized rats. The daily supply with progesterone
1 week before an ischemic event caused exacerbated brain
injury such as increased infarct size (Murphy et al. 2000).
Furthermore, progesterone was shown to increase inflam-
mation in cerebral vessels. The induction of an inflamma-
tory response was induced by injection of the bacterial
endotoxin lipopolysaccharide. Administration of estrogen
significantly reduced the inflammatory response measured
by cyclooxygenase 2 and nitric oxide synthase, whereas
progesterone increased the inflammatory reaction (Sunday
et al. 2006). Opposite effects of estrogen and progesterone
also emerged when comparing the results of this study
and our previous investigations, demonstrating signifi-
cantly attenuated hyperoxia-mediated apoptotic cell
degeneration of C8-D1A astrocytes following 17b-estra-
diol administration (Huppmann et al. 2008).
According to our initial assumption, many studies
describe protective qualities of progesterone in brain
tissue such as reduction of infarct size (Ishrat et al. 2009)
and survival rate and motor ability of mice after ischemic
stroke (Gibson and Murphy 2004). Same authors
reported furthermore that progesterone administration
during reperfusion and before ischemia lowered brain
injury (Murphy et al. 2000).
Most actions of progesterone are mediated by binding
to cytoplasmic progesterone receptors or through its
metabolite allopregnanolone which binds to GABA(A)
receptors (Gibson et al. 2009). To what extent the C8-
D1A astrocytes are able to convert progesterone in allo-
pregnanolone is unknown. This could explain the lack of
protection in our model. Also, the metabolism could be
blocked in hyperoxia. In brain cells the neuroprotective
potential of progesterone may be mainly mediated by
allopregnanolone via its modulation of GABA(A) recep-
tors. Therefore, repeating the experiments in primary
neuronal and astrocytic culture could confirm the thesis
and should be object for further investigations.
Experiments show that the classical progesterone recep-
tors PR play an important role in mediating neuroprotec-
tive effects of progesterone (Liu et al. 2012). However,
there is evidence for membrane associated progesterone
receptors mediating effects of progesterone in the CNS
(Guennoun et al. 2008). So far, it is not clear if the mem-
brane associated receptors are expressed in astrocytes and
therefore could play a role in mediating neuroprotective
effects in this cell type.
In conclusion, this study could not prove a protective
effect of progesterone on hyperoxia-induced cell damage
in mouse astrocytes. Our experiments could not specify
what part of the decrease in MTT reduction is due to
inhibition of proliferation, apoptosis, or necrosis. Further
investigations are required to clarify the question whether
maintaining the placental hormone level after preterm
birth is a promising therapeutic strategy. There is still
need to specify neuroprotective elements to improve
long-time outcome of preterm infants.
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